Colchicine and COVID-19
Loading...
Date
2020
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
The Journal of Clinical Pharmacology
item.page.issn
1552-4604
item.page.isbn
item.page.source
The Journal of Clinical Pharmacology, 60, 978-978.
Abstract
Description
In Argentina, we started COLCOVID Trial to test the effects of colchicine on moderate-/high-risk hospitalized COVID-19 patients with the aim of reducing mortality. This study is a phase 3 multicenter, controlled trial; our protocol was published in ClinicalTrial.gov on March 31, 2020.
Fil: Corral, Pablo. Universidad FASTA. Facultad de Ciencias Médicas; Argentina.
Fil: Corral, Gonzalo. Clínica 25 de Mayo. Hospital Interzonal General de Agudos "Dr. Oscar E. Alende". Servicio de Infectología; Argentina
Fil: Diaz, Rafael. Estudios Cardiológicos Latinoamérica. Instituto Cardiovascular de Rosario; Argentina
Fil: Corral, Pablo. Universidad FASTA. Facultad de Ciencias Médicas; Argentina.
Fil: Corral, Gonzalo. Clínica 25 de Mayo. Hospital Interzonal General de Agudos "Dr. Oscar E. Alende". Servicio de Infectología; Argentina
Fil: Diaz, Rafael. Estudios Cardiológicos Latinoamérica. Instituto Cardiovascular de Rosario; Argentina
Keywords
Citation
Corral, P., Corral, G. and Diaz, R. (2020), Colchicine and COVID-19. The Journal of Clinical Pharmacology, 60: 978-978. https://doi.org/10.1002/jcph.1684